Loading institutional data...
Loading institutional data...
Insufficient data to determine institutional momentum.
Data as of Q1 2026
Loading snapshot...
Loading financials...
Loading valuation...
Loading quality & risk...
Loading dividends & returns...
Loading capital allocation...
Loading debt & leverage...
Loading performance...
Loading peer comparison...
Loading ownership map...
Loading crowding analysis...
Loading conviction analysis...
Loading buy/sell flow...
Loading ownership trends...
Loading top holders...
Loading top holders...
Total shares institutions bought (green) vs sold (red) each quarter across all holders.
Inferred from quarter-over-quarter change in each fund's 13F position (new stakes count as buys, exits as sells). Not tick-level trades.
Solve the discounted cash flow backwards, then stress-test the assumptions.
To be worth $16.22 today, the market must believe free cash flow compounds -1.8%/yr for a decade (off $64M normalized FCF).
The market's -1.8% is more conservative than its 9-yr track record.
2-stage DCF · 0.04B shares · net debt $69M
mean 69.3% · volatility σ 250% · implied rate exceeded in 4/8 yrs
Central path = implied -1.8%/yr growth; shaded band = ±1σ (250%) of this company's historical FCF volatility, widening with time. The wider the band, the less certain the growth.
Reverse DCF: rather than guessing a fair value, we solve for the growth the current price implies, then you stress-test the assumptions. Enterprise value of the FCF stream, less net debt, ÷ shares. Educational — not a recommendation.
No trend data available for this metric.
Total return (dividends reinvested) vs the market, from quarter-end prices.
Above 0 = ahead of the S&P 500 since the window start; below 0 = behind. Rising means it's pulling ahead.
How far the stock fell below its prior peak. Deeper, longer drawdowns = a rougher ride to the same return.
Quarter-end, dividend-adjusted (total return). Beta & volatility from quarterly returns (annualized). Benchmark is the S&P 500 (SPY total return). Annual returns compound the quarters ending in each calendar year; the first and last years in a window may be partial. Past performance doesn't predict future results.
EOD close · as of 2026-09-17
How a revenue dollar becomes profit — FY2025
Each value shows its share of revenue below it (common-size).
| Line Item | FY2025 | FY2024 | FY2023 | FY2023 | FY2022 | FY2021 | FY2019 | FY2018 | FY2017 | FY2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $4.25B 100.0% | $4.33B 100.0% | $4.84B 100.0% | $4.97B 100.0% | $4.91B 100.0% | $4.52B 100.0% | $5.36B 100.0% | $5.51B 100.0% | $5.37B 100.0% | $5.28B 100.0% |
| Cost of Revenue | $3.40B 79.9% | $3.45B 79.6% | $3.87B 80.1% | $3.95B 79.6% | $3.99B 81.3% | $3.69B 81.7% | $4.39B 81.9% | $4.54B 82.4% | $4.42B 82.2% | $4.37B 82.8% |
| Cost of Services | — | — | — | — | — | — | — | — | $4.42B 82.2% | $4.37B 82.8% |
| Gross Profit | $853.0M 20.1% | $882.6M 20.4% | $961.4M 19.9% | $1.01B 20.4% | $919.2M 18.7% | $827.6M 18.3% | $968.4M 18.1% | $972.2M 17.6% | $954.1M 17.8% | $906.3M 17.2% |
| Selling, General & Admin | $825.9M 19.4% | $818.4M 18.9% | $934.7M 19.3% | $943.5M 19.0% | $870.6M 17.7% | $805.6M 17.8% | $883.1M 16.5% | $884.8M 16.0% | $870.8M 16.2% | $843.1M 16.0% |
| Operating Income | -$69.8M -1.6% | -$15.1M -0.3% | $24.3M 0.5% | $14.8M 0.3% | $48.6M 1.0% | -$93.6M -2.1% | $81.8M 1.5% | $87.4M 1.6% | $83.3M 1.5% | $63.2M 1.2% |
| Interest Expense | $12.4M 0.3% | $10.9M 0.3% | $3.2M 0.1% | $2.1M 0.0% | $2.5M 0.1% | $3.0M 0.1% | $4.2M 0.1% | $3.1M 0.1% | $2.7M 0.1% | $3.8M 0.1% |
| Interest & Investment Income | $3.7M 0.1% | $6.8M 0.2% | $6.7M 0.1% | $2.3M 0.0% | $200K 0.0% | $600K 0.0% | $1.1M 0.0% | $800K 0.0% | $700K 0.0% | $400K 0.0% |
| Other Income (Expense), net | -$9.0M -0.2% | -$6.8M -0.2% | $600K 0.0% | $1.6M 0.0% | -$3.6M -0.1% | $3.4M 0.1% | -$1.2M -0.0% | -$600K -0.0% | -$1.6M -0.0% | -$700K -0.0% |
| Pretax Income | -$78.8M -1.9% | -$21.9M -0.5% | $24.9M 0.5% | -$71.2M -1.4% | $185.8M 3.8% | -$106.8M -2.4% | $116.4M 2.2% | -$9.4M -0.2% | $81.7M 1.5% | $149.7M 2.8% |
| Income Tax Expense | $175.3M 4.1% | -$21.3M -0.5% | -$11.5M -0.2% | -$7.9M -0.2% | $35.1M 0.7% | -$34.0M -0.8% | $400K 0.0% | -$27.1M -0.5% | $12.8M 0.2% | $30.0M 0.6% |
| Net Income | -$600K -0.0% | -$600K -0.0% | $36.4M 0.8% | -$62.5M -1.3% | $156.1M 3.2% | -$72.0M -1.6% | $112.4M 2.1% | $22.9M 0.4% | $71.6M 1.3% | $120.8M 2.3% |
| Per Share | ||||||||||
| EPS (Basic) | $-7.24 | $-0.02 | $0.99 | $-1.64 | $3.93 | $-1.83 | $2.85 | $0.59 | $1.84 | $3.10 |
| EPS (Diluted) | $-7.24 | $-0.02 | $0.98 | $-1.64 | $3.91 | $-1.83 | $2.84 | $0.58 | $1.81 | $3.08 |
| Weighted Avg Shares (Basic) | 35.1M | 35.5M | 35.9M | 38.1M | 39.4M | 39.3M | 39.1M | 38.8M | 38.3M | 38.1M |
| Weighted Avg Shares (Diluted) | 35.1M | 35.5M | 36.3M | 38.1M | 39.5M | 39.3M | 39.2M | 39.1M | 39.0M | 38.4M |
Source: SEC EDGAR XBRL filings (annual, fiscal year). Quarterly flow items are derived from cumulative filings; balance-sheet figures are as-of each period end. Ratios and margins are computed, not reported.
Is the value real, and is the business safe? Academic scores + earnings quality + solvency, from SEC filings.
Insufficient balance-sheet detail (needs retained earnings, working capital, equity).
Eight indices comparing this year to last (receivables, margins, asset quality, growth, accruals, leverage). Above −1.78 suggests possible manipulation; below −2.22 is clean.
A screen, not proof — high growth alone can raise it.
Cash-conversion data unavailable. Lower/negative accruals = higher quality (Sloan).
Interest coverage is thin — monitor; leverage falling year-over-year.
F-Score (0–9 fundamental momentum), Altman Z (distress risk), and Beneish M (earnings-manipulation screen) are academic models computed from the SEC filings. Screens and context — educational, not recommendations.
What the company returns to shareholders — and whether it's covered by cash.
The dividend is comfortably covered — only 10% of free cash flow, leaving room to grow it and fund buybacks. Last year: $11M dividends + $0 buybacks = $11M returned on $114M FCF.
5 consecutive years of dividend increases · 1%/yr.
Yields use the latest fiscal-year dividends/buybacks over current market cap. Dividends and buybacks from the SEC cash-flow statement; payout coverage vs net income and free cash flow. Educational — not a recommendation.
How management deployed cash over 10 years — and what it earned on reinvestment.
A reinvestment story — most cash went back into growth rather than to shareholders.
Operating income fell despite reinvestment — a warning on capital productivity. Current ROIC on all capital: -24%. Rough measure (includes maintenance capex).
Cash uses aggregated from the SEC cash-flow statement over 10 fiscal years. "Return on reinvestment" is a rough proxy — operating-income change ÷ cumulative CapEx + M&A — and includes maintenance capex. Educational — not a recommendation.
How much the company owes, how it's trended, and how comfortably it's serviced.
Green ≤ 1.5× · amber ≤ 3× · red > 3× (leverage relative to cash earnings).
Thin coverage — earnings barely cover interest. Effective rate ~12.2% on $102M of debt.
Cash vs short-term debt unavailable.
Mostly long-term debt (balance-sheet current vs non-current split). A year-by-year maturity schedule wasn't disclosed for this issuer.
Debt, cash, interest and equity from the SEC balance sheet & income statement. Effective rate = interest ÷ average debt. Educational — not a recommendation.
EOD close · as of 2026-09-17
No standout strengths flagged.
Is the profit real, and how strong is the balance sheet?
FY2025 · every deduction from revenue to net income
DuPont — the three levers
Watch the leverage lever — a chunk of ROE comes from the balance sheet.
What the company owes vs. what it holds
Year-by-year maturities aren't in SEC companyfacts (footnote-only), so this shows the debt/cash structure and net leverage instead.
Latest year: profit growth vs revenue growth
Profit and sales moved in opposite directions this year.
Each line as % of revenue — the trend in color
| % of revenue | FY2018 | FY2019 | FY2021 | FY2022 | FY2023 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|
| Cost of Revenue | 82.4 | 81.9 | 81.7 | 81.3 | 79.6 | 80.1 | 79.6 | 79.9 |
| Gross Profit | 17.6 | 18.1 | 18.3 | 18.7 | 20.4 | 19.9 | 20.4 | 20.1 |
| SG&A | 16.0 | 16.5 | 17.8 | 17.7 | 19.0 | 19.3 | 18.9 | 19.4 |
| Operating Income | 1.6 | 1.5 | -2.1 | 1.0 | 0.3 | 0.5 | -0.3 | -1.6 |
| Income Tax | -0.5 | 0.0 | -0.8 | 0.7 | -0.2 | -0.2 | -0.5 | 4.1 |
| Net Income | 0.4 | 2.1 | -1.6 | 3.2 | -1.3 | 0.8 | -0.0 | -0.0 |
Green = margin-favorable vs the row's own range · red = unfavorable.
The metrics that matter, over time
A 30-second read on KELYA: price, valuation, headline fundamentals, and an auto-generated scorecard from SEC filings. Flags are rule-based signals, not recommendations.
Ranked against 651 sector peers with collected financials. Valuation from latest close × latest fiscal-year fundamentals; 13F conviction as of 2026-03-31.
Percentile is “goodness” within the peer set (100 = best). For valuation and leverage that means cheaper / less-levered ranks higher.
| Company | Mkt cap ▼ | P/E | EV/EBITDA | P/S | Rev gr | Gross | Net | ROE | ROIC | Net D/EBITDA | 13F |
|---|---|---|---|---|---|---|---|---|---|---|---|
| LTM | $29.49T | — | — | — | — | — | — | — | — | — | 160 |
| CAT | $371.6B | 42.5× | 29.7× | 5.5× | 4.3% | 33.8% | 13.1% | 41.7% | 15.4% | 2.7× | 3,616 |
| GE | $328.8B | 38.5× | — | 7.2× | 18.5% | — | 19.0% | 46.6% | 22.2% | — | 3,077 |
| RTX | $259.8B | 39.0× | 18.5× | 2.9× | 9.7% | — | 7.6% | 10.3% | 10.3% | 0.0× | 3,277 |
| BA | $199.4B | 79.4× | 40.2× | 2.2× | 34.5% | 4.8% | 2.5% | 41.0% | 3.3% | 10.0× | 2,435 |
| DE | $185.4B | 37.1× | — | 4.1× | -11.7% | — | 11.0% | 19.4% | 12.6% | — | 2,491 |
| ABBNY | $177.4B | 47.9× | 31.6× | 5.5× | 9.5% | 34.8% | 11.9% | 28.5% | 20.4% | 0.9× | 48 |
| UNP | $167.6B | 23.6× | 16.1× | 6.8× | 1.1% | — | 29.1% | 38.7% | 14.2% | 2.6× | 2,648 |
| ETN | $158.8B | 39.2× | — | 5.8× | 10.3% | 37.6% | 14.9% | 21.0% | 13.9% | — | 2,398 |
| HON | $131.2B | 28.1× | 16.1× | 3.5× | 7.8% | 36.9% | 12.6% | 34.0% | 9.8% | 3.6× | 2,694 |
| LMT | $123.2B | 25.0× | 16.1× | 1.6× | 5.6% | 10.2% | 6.7% | 74.6% | 17.7% | 2.5× | 2,807 |
| PH | $118.7B | 34.1× | 26.8× | 6.0× | -0.4% | 36.9% | 17.8% | 25.8% | 16.7% | 1.6× | 1,845 |
| ADP | $108.3B | 24.9× | — | 4.9× | 6.7% | 46.4% | 20.1% | 73.2% | 40.1% | — | 2,179 |
| GD | $96.2B | 23.0× | 16.9× | 1.8× | 10.1% | — | 8.0% | 16.4% | 12.5% | 1.3× | 2,123 |
| TT | $94.4B | 32.6× | 23.3× | 4.4× | 7.5% | — | 13.7% | 34.0% | 22.1% | 1.1× | 1,658 |
| VRT | $92.4B | 70.8× | 43.8× | 9.0× | 27.7% | 36.3% | 13.0% | 33.8% | 19.4% | 1.4× | 1,748 |
| PWR | $92.2B | 90.7× | 45.8× | 3.2× | 20.3% | 15.0% | 3.6% | 11.5% | 10.6% | 0.4× | 1,659 |
| JCI | $91.9B | 28.0× | — | 3.9× | 2.8% | 36.4% | 13.9% | 25.5% | 14.4% | — | 1,487 |
| HWM | $90.7B | 60.9× | 39.9× | 11.0× | 11.1% | — | 18.3% | 28.2% | 17.9% | 1.3× | 1,399 |
| CSX | $89.1B | 31.1× | 14.4× | 6.3× | -3.1% | — | 20.5% | 22.0% | 22.0% | — | 1,791 |
| MMM | $87.3B | 27.4× | 16.8× | 3.5× | 1.5% | 39.9% | 13.0% | 69.1% | 18.8% | 2.1× | 2,051 |
| WM | $86.0B | 31.8× | 12.1× | 3.4× | 14.2% | 40.4% | 10.7% | 27.1% | 25.3% | 0.1× | 2,262 |
| UPS | $85.0B | 15.3× | 9.5× | 1.0× | -2.6% | — | 6.3% | 34.3% | 13.8% | 2.2× | 2,025 |
| EMR | $83.0B | 36.5× | — | 4.6× | 3.0% | 52.8% | 12.7% | 11.3% | 6.9% | — | 2,112 |
| CTAS | $79.8B | 45.0× | 28.7× | 7.7× | 7.7% | 50.0% | 17.5% | 38.7% | 25.5% | 0.8× | 1,366 |
| KELYA | $569M | — | — | 0.1× | -1.9% | 20.1% | -6.0% | -26.0% | -23.6% | -3.7× | 154 |
Peers = companies sharing KELYA's sector (Industrials) with collected SEC financials. Multiples use the most recent end-of-day close and latest fiscal-year fundamentals (trailing, not forward). Missing cells mean the peer never reported that line item, has no collected price, or has a non-positive denominator. Not investment advice.
Top 40 institutional holders — bubble size is position value, color is the move since last quarter. Hover any holder for detail.
Drag any bubble to rearrange · size = dollar value of the position